| J9299 | Injection, nivolumab, 1 mg | 59,680 | $20 | $1.3M |
| J9228 | Injection, ipilimumab, 1 mg | 5,290 | $110 | $592.5K |
| J1442 | Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram | 148,620 | $1 | $148.6K |
| J0897 | Injection, denosumab, 1 mg | 6,900 | $20 | $117.3K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 620 | $100 | $60.7K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 2,510 | $20 | $55.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 760 | $70 | $50.4K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 300 | $100 | $28.7K |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | 4,360 | $10 | $26.2K |
| 96417 | In this add–on procedure, the provider continues administration of a chemotherapy drug into a vein using an infusion technique. He uses this code to report administration of a different chemotherapy… | 350 | $50 | $16.8K |